NAGE
Niagen Bioscience, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$368.37M
P/E Ratio
23.00
EPS
$0.20
Beta
2.23
52W High
$14.69
52W Low
$4.16
50-Day MA
$5.06
200-Day MA
$7.73
Dividend Yield
—
Profit Margin
13.40%
Forward P/E
16.84
PEG Ratio
—
About Niagen Bioscience, Inc.
Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | $129.42M |
| Gross Profit (TTM) | $83.19M |
| EBITDA | $15.08M |
| Operating Margin | 6.22% |
| Return on Equity | 28.30% |
| Return on Assets | 10.20% |
| Revenue/Share (TTM) | $1.64 |
| Book Value | $0.96 |
| Price-to-Book | 4.58 |
| Price-to-Sales (TTM) | 2.85 |
| EV/Revenue | 2.232 |
| EV/EBITDA | 18.35 |
| Quarterly Earnings Growth (YoY) | -41.60% |
| Quarterly Revenue Growth (YoY) | 16.20% |
| Shares Outstanding | $80.08M |
| Float | $52.89M |
| % Insiders | 33.89% |
| % Institutions | 41.75% |
Historical Volatility
HV 10-Day
47.60%
HV 20-Day
48.27%
HV 30-Day
45.48%
HV 60-Day
44.27%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($13.60 target)
5
BuyData last updated: 4/9/2026